by rss feed | Apr 19, 2026 | FDA, News Feeds, Vinay Prasad, weekly reads
Vinay Prasad has only less than two weeks left at the FDA atop CBER. I’ve been trying to imagine where CBER goes from here after he exits. It feels like FDA Commissioner Marty Makary and RFK Jr. will likely be the real leaders of CBER moving forward on key...
by rss feed | Nov 2, 2025 | CBER Director, News Feeds, Vinay Prasad, weekly reads
It seems like there’s still chaos inside the FDA’s biologics branch CBER led by Vinay Prasad. As many of you will remember, Prasad was forced out shortly after becoming CBER Director earlier this year. Then Makary and RFK Jr. pushed successfully to bring...
by rss feed | Sep 28, 2025 | FDA, News Feeds, Vinay Prasad, weekly reads
The conservative Wall Street Journal continues to go after FDA CBER Director Vinay Prasad. WSJ still doesn’t like CBER Director Vinay Prasad What’s going on? Here’s a new piece from the paper’s editorial board: Dr. Prasad, the FDA’s Grim...
by rss feed | Aug 3, 2025 | aging stem cells, Ewa Zuba-Surma, Mariusz Ratajczak, News Feeds, Vinay Prasad, weekly reads
It’s been a big couple of weeks of chaotic developments at the FDA including the ousting of CBER director Vinay Prasad. The Sarepta rollercoaster was tied to that. If such recent events are any indication of how the next 3+ years are going to play out at the...
by rss feed | May 6, 2025 | News Feeds, stem cell politics, Tracy Hoeg, Vinay Prasad
The FDA has a new CBER Director Dr. Vinay Prasad. CBER is the FDA’s biologics branch that handles things like cell therapies and vaccines. The branch has been in near-constant upheaval this year. For a time, Scott Steele was acting CBER Director. It wasn’t...
